project id: TCGA-KIRP; case submitter id: TCGA-B1-A657; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 2.12; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 7.5; age at index: 54; days to birth: -19806; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 19806; ajcc clinical m: M0; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 641.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: Yes; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 355; initial weight: 240.0; sample id: 2d5ece93-2155-4cf0-996c-184e42fc4c0f; sample submitter id: TCGA-B1-A657-01A; portion id: 8f524c06-ebc4-4c26-98e6-fe97e6d951dc; portion submitter id: TCGA-B1-A657-01A-11; slide id: 7b4832c3-7260-4827-b83b-5c3f42eee632; slide submitter id: TCGA-B1-A657-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;